Designation: Professor
Department: Biomedical Sciences
University: Ulster University
Country: United Kingdom
Professor Tara Moore's illustrious career in biomedical sciences exemplifies her dedication to advancing research and improving healthcare outcomes. With a Ph.D. from Harvard University and extensive experience in prestigious institutions across the UK, Europe, and the USA, she has made significant strides in the field of blinding eye diseases.
As the Director of the Biomedical Sciences Research Institute at Ulster University, Professor Moore plays a pivotal role in leading research efforts and fostering a culture of innovation and excellence. Her leadership extends to overseeing a large team of staff and researchers, as well as guiding numerous Ph.D. students in their research endeavors.
One of Professor Moore's key contributions lies in her pioneering work on novel diagnosis and treatment methods for blinding eye diseases. By leveraging her expertise and collaborative approach, she has spearheaded groundbreaking research initiatives aimed at translating scientific discoveries into tangible clinical benefits for patients. Her commitment to personalized medicine approaches has paved the way for more effective and targeted treatments, ultimately improving patient outcomes.
Professor Moore's remarkable achievements have garnered widespread recognition, including the prestigious WISE award presented by HRH Princess Anne. This accolade underscores her significant impact on health, well-being, and safety, as well as her role as an inspiring leader in the scientific community. Most recently, she was honored with a Winston Churchill Fellowship, further highlighting her dedication to driving positive change through science and innovation.
Through her visionary leadership, groundbreaking research, and commitment to making a difference, Professor Tara Moore continues to inspire others and leave a lasting legacy in the field of biomedical sciences. Her contributions to advancing knowledge and improving lives serve as a testament to the transformative power of scientific inquiry and innovation.
Her research interest, mainly focuses on developing siRNA and CRISPR-Cas9 for the cornea paving the way for gene silencing and gene editing in corneal dystrophies, developing remarkably potent mutant allele specific siRNAs and PAM specific CRISPR-Cas9 technologies.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.